ASCL2 and cancer: LeuAAG-001-N-3p-68-85 was validated to target UPF1, a regulator of mRNA decay [19], while AlaAGC-002-N-3p-58-75 was linked to the suppression of ASCL2, a transcription factor involved in cancer progression [18].